nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Vulvovaginal mycotic infection—Doxorubicin—ovarian cancer	0.00525	0.00525	CcSEcCtD
Cefoxitin—Colitis—Paclitaxel—ovarian cancer	0.00521	0.00521	CcSEcCtD
Cefoxitin—Local reaction—Doxorubicin—ovarian cancer	0.00519	0.00519	CcSEcCtD
Cefoxitin—Candida infection—Paclitaxel—ovarian cancer	0.00518	0.00518	CcSEcCtD
Cefoxitin—Jaundice—Melphalan—ovarian cancer	0.00504	0.00504	CcSEcCtD
Cefoxitin—Erythema multiforme—Chlorambucil—ovarian cancer	0.00503	0.00503	CcSEcCtD
Cefoxitin—Rash maculo-papular—Paclitaxel—ovarian cancer	0.00494	0.00494	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Docetaxel—ovarian cancer	0.00487	0.00487	CcSEcCtD
Cefoxitin—Pancytopenia—Vinorelbine—ovarian cancer	0.00481	0.00481	CcSEcCtD
Cefoxitin—Haemoglobin—Topotecan—ovarian cancer	0.00476	0.00476	CcSEcCtD
Cefoxitin—Haemorrhage—Topotecan—ovarian cancer	0.00474	0.00474	CcSEcCtD
Cefoxitin—Neutropenia—Vinorelbine—ovarian cancer	0.00474	0.00474	CcSEcCtD
Cefoxitin—Haemoglobin—Melphalan—ovarian cancer	0.00466	0.00466	CcSEcCtD
Cefoxitin—Haemorrhage—Melphalan—ovarian cancer	0.00464	0.00464	CcSEcCtD
Cefoxitin—Bone marrow depression—Epirubicin—ovarian cancer	0.0046	0.0046	CcSEcCtD
Cefoxitin—Urinary tract disorder—Melphalan—ovarian cancer	0.00458	0.00458	CcSEcCtD
Cefoxitin—Phlebitis—Paclitaxel—ovarian cancer	0.00457	0.00457	CcSEcCtD
Cefoxitin—Thrombophlebitis—Paclitaxel—ovarian cancer	0.00455	0.00455	CcSEcCtD
Cefoxitin—Urethral disorder—Melphalan—ovarian cancer	0.00455	0.00455	CcSEcCtD
Cefoxitin—Colitis—Docetaxel—ovarian cancer	0.00442	0.00442	CcSEcCtD
Cefoxitin—Candida infection—Docetaxel—ovarian cancer	0.00439	0.00439	CcSEcCtD
Cefoxitin—Flushing—Melphalan—ovarian cancer	0.00431	0.00431	CcSEcCtD
Cefoxitin—Anaemia—Chlorambucil—ovarian cancer	0.00428	0.00428	CcSEcCtD
Cefoxitin—Renal failure acute—Paclitaxel—ovarian cancer	0.00427	0.00427	CcSEcCtD
Cefoxitin—Bone marrow depression—Doxorubicin—ovarian cancer	0.00425	0.00425	CcSEcCtD
Cefoxitin—Angioedema—Chlorambucil—ovarian cancer	0.00423	0.00423	CcSEcCtD
Cefoxitin—Agranulocytosis—Vinorelbine—ovarian cancer	0.00421	0.00421	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00418	0.00418	CcSEcCtD
Cefoxitin—Leukopenia—Chlorambucil—ovarian cancer	0.00415	0.00415	CcSEcCtD
Cefoxitin—Convulsion—Chlorambucil—ovarian cancer	0.00401	0.00401	CcSEcCtD
Cefoxitin—Phlebitis—Docetaxel—ovarian cancer	0.00388	0.00388	CcSEcCtD
Cefoxitin—Thrombophlebitis—Docetaxel—ovarian cancer	0.00386	0.00386	CcSEcCtD
Cefoxitin—Anaemia—Topotecan—ovarian cancer	0.00381	0.00381	CcSEcCtD
Cefoxitin—Angioedema—Topotecan—ovarian cancer	0.00377	0.00377	CcSEcCtD
Cefoxitin—Flushing—Vinorelbine—ovarian cancer	0.00376	0.00376	CcSEcCtD
Cefoxitin—Anaemia—Melphalan—ovarian cancer	0.00373	0.00373	CcSEcCtD
Cefoxitin—Thrombocytopenia—Chlorambucil—ovarian cancer	0.0037	0.0037	CcSEcCtD
Cefoxitin—Leukopenia—Topotecan—ovarian cancer	0.00369	0.00369	CcSEcCtD
Cefoxitin—Leukopenia—Melphalan—ovarian cancer	0.00362	0.00362	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00355	0.00355	CcSEcCtD
Cefoxitin—Erythema—Vinorelbine—ovarian cancer	0.00353	0.00353	CcSEcCtD
Cefoxitin—Convulsion—Melphalan—ovarian cancer	0.0035	0.0035	CcSEcCtD
Cefoxitin—Anaphylactic shock—Topotecan—ovarian cancer	0.00337	0.00337	CcSEcCtD
Cefoxitin—Anaphylactic shock—Melphalan—ovarian cancer	0.0033	0.0033	CcSEcCtD
Cefoxitin—Thrombocytopenia—Topotecan—ovarian cancer	0.0033	0.0033	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Epirubicin—ovarian cancer	0.00328	0.00328	CcSEcCtD
Cefoxitin—Anaemia—Vinorelbine—ovarian cancer	0.00326	0.00326	CcSEcCtD
Cefoxitin—Pancytopenia—Paclitaxel—ovarian cancer	0.00324	0.00324	CcSEcCtD
Cefoxitin—Pain—Chlorambucil—ovarian cancer	0.00323	0.00323	CcSEcCtD
Cefoxitin—Thrombocytopenia—Melphalan—ovarian cancer	0.00323	0.00323	CcSEcCtD
Cefoxitin—Angioedema—Vinorelbine—ovarian cancer	0.00322	0.00322	CcSEcCtD
Cefoxitin—Neutropenia—Paclitaxel—ovarian cancer	0.00319	0.00319	CcSEcCtD
Cefoxitin—Leukopenia—Vinorelbine—ovarian cancer	0.00316	0.00316	CcSEcCtD
Cefoxitin—Vaginal inflammation—Epirubicin—ovarian cancer	0.0031	0.0031	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00309	0.00309	CcSEcCtD
Cefoxitin—Hypotension—Melphalan—ovarian cancer	0.00308	0.00308	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.00304	0.00304	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00301	0.00301	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00301	0.00301	CcSEcCtD
Cefoxitin—Urticaria—Chlorambucil—ovarian cancer	0.003	0.003	CcSEcCtD
Cefoxitin—Dyspnoea—Topotecan—ovarian cancer	0.003	0.003	CcSEcCtD
Cefoxitin—Body temperature increased—Chlorambucil—ovarian cancer	0.00299	0.00299	CcSEcCtD
Cefoxitin—Abdominal pain—Chlorambucil—ovarian cancer	0.00299	0.00299	CcSEcCtD
Cefoxitin—Colitis—Epirubicin—ovarian cancer	0.00298	0.00298	CcSEcCtD
Cefoxitin—Candida infection—Epirubicin—ovarian cancer	0.00296	0.00296	CcSEcCtD
Cefoxitin—Dyspnoea—Melphalan—ovarian cancer	0.00294	0.00294	CcSEcCtD
Cefoxitin—Vaginal infection—Epirubicin—ovarian cancer	0.00293	0.00293	CcSEcCtD
Cefoxitin—Aplastic anaemia—Epirubicin—ovarian cancer	0.00291	0.00291	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00288	0.00288	CcSEcCtD
Cefoxitin—Pain—Topotecan—ovarian cancer	0.00288	0.00288	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00287	0.00287	CcSEcCtD
Cefoxitin—Rash maculo-papular—Epirubicin—ovarian cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Pain—Melphalan—ovarian cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00279	0.00279	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—ovarian cancer	0.00276	0.00276	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Topotecan—ovarian cancer	0.00275	0.00275	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—ovarian cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Pancytopenia—Docetaxel—ovarian cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Haemoglobin—Paclitaxel—ovarian cancer	0.00274	0.00274	CcSEcCtD
Cefoxitin—Haemorrhage—Paclitaxel—ovarian cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—ovarian cancer	0.00271	0.00271	CcSEcCtD
Cefoxitin—Neutropenia—Docetaxel—ovarian cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—ovarian cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Cefoxitin—Hypotension—Vinorelbine—ovarian cancer	0.00269	0.00269	CcSEcCtD
Cefoxitin—Pruritus—Chlorambucil—ovarian cancer	0.00268	0.00268	CcSEcCtD
Cefoxitin—Urticaria—Topotecan—ovarian cancer	0.00267	0.00267	CcSEcCtD
Cefoxitin—Urethral disorder—Paclitaxel—ovarian cancer	0.00267	0.00267	CcSEcCtD
Cefoxitin—Body temperature increased—Topotecan—ovarian cancer	0.00266	0.00266	CcSEcCtD
Cefoxitin—Abdominal pain—Topotecan—ovarian cancer	0.00266	0.00266	CcSEcCtD
Cefoxitin—Urticaria—Melphalan—ovarian cancer	0.00262	0.00262	CcSEcCtD
Cefoxitin—Phlebitis—Epirubicin—ovarian cancer	0.00262	0.00262	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—ovarian cancer	0.00261	0.00261	CcSEcCtD
Cefoxitin—Thrombophlebitis—Epirubicin—ovarian cancer	0.0026	0.0026	CcSEcCtD
Cefoxitin—Diarrhoea—Chlorambucil—ovarian cancer	0.00259	0.00259	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00258	0.00258	CcSEcCtD
Cefoxitin—Erythema multiforme—Paclitaxel—ovarian cancer	0.00258	0.00258	CcSEcCtD
Cefoxitin—Dyspnoea—Vinorelbine—ovarian cancer	0.00257	0.00257	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00255	0.00255	CcSEcCtD
Cefoxitin—Flushing—Paclitaxel—ovarian cancer	0.00253	0.00253	CcSEcCtD
Cefoxitin—Jaundice—Docetaxel—ovarian cancer	0.00251	0.00251	CcSEcCtD
Cefoxitin—Hypersensitivity—Topotecan—ovarian cancer	0.00248	0.00248	CcSEcCtD
Cefoxitin—Pain—Vinorelbine—ovarian cancer	0.00246	0.00246	CcSEcCtD
Cefoxitin—Renal failure acute—Epirubicin—ovarian cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Hypersensitivity—Melphalan—ovarian cancer	0.00243	0.00243	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—ovarian cancer	0.00242	0.00242	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00241	0.00241	CcSEcCtD
Cefoxitin—Vomiting—Chlorambucil—ovarian cancer	0.0024	0.0024	CcSEcCtD
Cefoxitin—Agranulocytosis—Docetaxel—ovarian cancer	0.0024	0.0024	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00239	0.00239	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00239	0.00239	CcSEcCtD
Cefoxitin—Pruritus—Topotecan—ovarian cancer	0.00238	0.00238	CcSEcCtD
Cefoxitin—Erythema—Paclitaxel—ovarian cancer	0.00237	0.00237	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Pruritus—Melphalan—ovarian cancer	0.00233	0.00233	CcSEcCtD
Cefoxitin—Haemoglobin—Docetaxel—ovarian cancer	0.00232	0.00232	CcSEcCtD
Cefoxitin—Haemorrhage—Docetaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Cefoxitin—Diarrhoea—Topotecan—ovarian cancer	0.0023	0.0023	CcSEcCtD
Cefoxitin—Urticaria—Vinorelbine—ovarian cancer	0.00229	0.00229	CcSEcCtD
Cefoxitin—Urinary tract disorder—Docetaxel—ovarian cancer	0.00228	0.00228	CcSEcCtD
Cefoxitin—Abdominal pain—Vinorelbine—ovarian cancer	0.00228	0.00228	CcSEcCtD
Cefoxitin—Body temperature increased—Vinorelbine—ovarian cancer	0.00228	0.00228	CcSEcCtD
Cefoxitin—Urethral disorder—Docetaxel—ovarian cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—ovarian cancer	0.00226	0.00226	CcSEcCtD
Cefoxitin—Diarrhoea—Melphalan—ovarian cancer	0.00226	0.00226	CcSEcCtD
Cefoxitin—Nausea—Chlorambucil—ovarian cancer	0.00225	0.00225	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00221	0.00221	CcSEcCtD
Cefoxitin—Anaemia—Paclitaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Cefoxitin—Erythema multiforme—Docetaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Cefoxitin—Angioedema—Paclitaxel—ovarian cancer	0.00217	0.00217	CcSEcCtD
Cefoxitin—Flushing—Docetaxel—ovarian cancer	0.00214	0.00214	CcSEcCtD
Cefoxitin—Vomiting—Topotecan—ovarian cancer	0.00214	0.00214	CcSEcCtD
Cefoxitin—Leukopenia—Paclitaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Rash—Topotecan—ovarian cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Dermatitis—Topotecan—ovarian cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Vomiting—Melphalan—ovarian cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Rash—Melphalan—ovarian cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Dermatitis—Melphalan—ovarian cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Convulsion—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Cefoxitin—Pruritus—Vinorelbine—ovarian cancer	0.00204	0.00204	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Erythema—Docetaxel—ovarian cancer	0.00201	0.00201	CcSEcCtD
Cefoxitin—Nausea—Topotecan—ovarian cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Diarrhoea—Vinorelbine—ovarian cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Nausea—Melphalan—ovarian cancer	0.00196	0.00196	CcSEcCtD
Cefoxitin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00194	0.00194	CcSEcCtD
Cefoxitin—Eosinophilia—Epirubicin—ovarian cancer	0.00193	0.00193	CcSEcCtD
Cefoxitin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.0019	0.0019	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00188	0.00188	CcSEcCtD
Cefoxitin—Anaemia—Docetaxel—ovarian cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Pancytopenia—Epirubicin—ovarian cancer	0.00185	0.00185	CcSEcCtD
Cefoxitin—Vomiting—Vinorelbine—ovarian cancer	0.00183	0.00183	CcSEcCtD
Cefoxitin—Neutropenia—Epirubicin—ovarian cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Rash—Vinorelbine—ovarian cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Dermatitis—Vinorelbine—ovarian cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Hypotension—Paclitaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Leukopenia—Docetaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—ovarian cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Convulsion—Docetaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Cefoxitin—Dyspnoea—Paclitaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Cefoxitin—Nausea—Vinorelbine—ovarian cancer	0.00171	0.00171	CcSEcCtD
Cefoxitin—Jaundice—Epirubicin—ovarian cancer	0.00169	0.00169	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—ovarian cancer	0.00169	0.00169	CcSEcCtD
Cefoxitin—Pain—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Cefoxitin—Agranulocytosis—Epirubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Haemoglobin—Epirubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Haemorrhage—Epirubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Urinary tract disorder—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Urticaria—Paclitaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Cefoxitin—Hypotension—Docetaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Abdominal pain—Paclitaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Body temperature increased—Paclitaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Urethral disorder—Epirubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Erythema multiforme—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Dyspnoea—Docetaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—ovarian cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Flushing—Epirubicin—ovarian cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Cefoxitin—Pain—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Pruritus—Paclitaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefoxitin—Erythema—Epirubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Cefoxitin—Diarrhoea—Paclitaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Cefoxitin—Body temperature increased—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Abdominal pain—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Cefoxitin—Anaemia—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Cefoxitin—Vomiting—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Cefoxitin—Rash—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Cefoxitin—Dermatitis—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Cefoxitin—Leukopenia—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefoxitin—Hypersensitivity—Docetaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefoxitin—Convulsion—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Cefoxitin—Pruritus—Docetaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefoxitin—Nausea—Paclitaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Cefoxitin—Diarrhoea—Docetaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Cefoxitin—Anaphylactic shock—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefoxitin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefoxitin—Vomiting—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Cefoxitin—Rash—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Cefoxitin—Hypotension—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefoxitin—Dermatitis—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Cefoxitin—Dyspnoea—Epirubicin—ovarian cancer	0.000987	0.000987	CcSEcCtD
Cefoxitin—Nausea—Docetaxel—ovarian cancer	0.000975	0.000975	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Cefoxitin—Pain—Epirubicin—ovarian cancer	0.000947	0.000947	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—ovarian cancer	0.000914	0.000914	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000906	0.000906	CcSEcCtD
Cefoxitin—Urticaria—Epirubicin—ovarian cancer	0.00088	0.00088	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—ovarian cancer	0.000876	0.000876	CcSEcCtD
Cefoxitin—Body temperature increased—Epirubicin—ovarian cancer	0.000875	0.000875	CcSEcCtD
Cefoxitin—Abdominal pain—Epirubicin—ovarian cancer	0.000875	0.000875	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000838	0.000838	CcSEcCtD
Cefoxitin—Hypersensitivity—Epirubicin—ovarian cancer	0.000816	0.000816	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—ovarian cancer	0.000814	0.000814	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—ovarian cancer	0.00081	0.00081	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—ovarian cancer	0.00081	0.00081	CcSEcCtD
Cefoxitin—Pruritus—Epirubicin—ovarian cancer	0.000784	0.000784	CcSEcCtD
Cefoxitin—Diarrhoea—Epirubicin—ovarian cancer	0.000758	0.000758	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000755	0.000755	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—ovarian cancer	0.000725	0.000725	CcSEcCtD
Cefoxitin—Vomiting—Epirubicin—ovarian cancer	0.000704	0.000704	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—ovarian cancer	0.000701	0.000701	CcSEcCtD
Cefoxitin—Rash—Epirubicin—ovarian cancer	0.000698	0.000698	CcSEcCtD
Cefoxitin—Dermatitis—Epirubicin—ovarian cancer	0.000698	0.000698	CcSEcCtD
Cefoxitin—Nausea—Epirubicin—ovarian cancer	0.000658	0.000658	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—ovarian cancer	0.000646	0.000646	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—ovarian cancer	0.000646	0.000646	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—ovarian cancer	0.000609	0.000609	CcSEcCtD
